Biocon Ltd Allots 87.86 Lakh Shares for Biologics Acquisition

Biocon Ltd has completed the acquisition of 1,15,36,956 equity shares of its material subsidiary, Biocon Biologics Limited (BBL), from 127 selling shareholders. In consideration, Biocon allotted 87,86,362 equity shares of face value Rs. 5 each at an issue price of Rs. 376.41 per share. This transaction, approved by shareholders via postal ballot on June 07, 2026, makes BBL a wholly-owned subsidiary of Biocon effective June 29, 2026. The allotment increases Biocon's paid-up equity share capital to Rs. 8,14,84,70,675, comprising 1,62,96,94,135 shares.